Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (ticker: CODX) is an NASDAQ-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of CODX's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. CODX reported $146K in revenue and -$9.14M for the period ending 2026-03-31, with operating cash flow of -$7.85M. Cash and equivalents stood at $8.23M (up 332.5% year-over-year). Total assets of $21.50M exceed total liabilities of $5.46M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

CODX Risk Flags

Consolidated view of every risk_flag row CODXhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	10-K · Mar 27, 2025	PCAOB-tagged auditor in 10-K filed 2025-03-27 (accession 0001641172-25-000932) was 'Tanner LLC' (PCAOB Firm ID: 270). Prior 10-K filed 2024-03-14 (accession 0001493152-24-009955) was 'Haynie & Company' (PCAOB Firm ID: 457).	view ↗

Related on CODX

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.